Catch pre-market movers with AI signals.
BLUE(Quitar la ciudad)
bluebird bio (BLUE) Stock Statistics, Valuation & Financial Metrics
Total Valuation
bluebird bio market cap is -- and enterprise value is --.
Share Statistics
bluebird bio has 9.79M shares outstanding, with a free float of 9.69M.
Valuation Ratios
bluebird bio's PE ratio is --, PB ratio is --, and PS ratio is --, showing whether the stock looks expensive or cheap.
Solvency
bluebird bio debt-to-equity ratio is -- and debt-to-assets ratio is 1.2.
Liquidity
bluebird bio's current ratio is 0.55, quick ratio is 0.29, and cash ratio is --, showing its short-term liquidity position.
Return on Capital
bluebird bio's ROE is --, ROA is --, and ROIC is --, showing its return on capital profile.
Profitability
bluebird bio gross margin is 27.12%, operating margin is -208.16%, and net margin is -192.39%.
Cost Structure
bluebird bio spends 83.60% of revenue on R&D and 146.04% on SG&A.
Operating Efficiency
bluebird bio's asset turnover is --, inventory turnover is --, and receivables turnover is --, indicating its operating efficiency.
Income Statement
bluebird bio's revenue is 103.95M, gross profit is 28.19M, net income is --, and EBITDA is --.
Balance Sheet
bluebird bio's total debt is --, net debt is --, total equity is --, and cash is --.
Cash Flow Statement
bluebird bio's operating cash flow is --, free cash flow is --, and CapEx is --.
Dividends & Yields
bluebird bio dividend yield is --, with a payout ratio of 0.00% and dividend per share of --.
Analyst Rating
bluebird bio's latest analyst rating is Unrate, with an analyst target price of --.
Company Info
A company that develops therapeutics to treat severe genetic and orphan diseases using gene therapy
Per Share Metrics
bluebird bio's EPS is --, book value per share is --, and free cash flow per share is --.
